Impact of 21-Gene Recurrence Score on Chemotherapy Decision in Invasive Ductal Carcinoma of Breast with Nodal Micrometastases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Impact of 21-Gene Recurrence Score on Chemotherapy Decision in Invasive Ductal Carcinoma of Breast with Nodal Micrometastases

Published:2019-10-15 Issue:4 Volume:51 Page:1437-1448
ISSN:1598-2998
Container-title:Cancer Research and Treatment
language:en
Short-container-title:Cancer Res Treat

Author:

Chen Wei-Rong,Deng Jia-Peng,Wang Jun,Sun Jia-Yuan,He Zhen-Yu,Wu San-Gang

Funder

National Natural Science Foundation of China

Natural Science Foundation of Fujian Province

Guangdong Academy of Sciences

Publisher

Korean Cancer Association

Subject

Cancer Research,Oncology

Link

http://e-crt.org/upload/pdf/crt-2018-611.pdf

Reference30 articles.

1. Stage migration due to introduction of the sentinel node procedure: a population-based study

2. Introduction of sentinel node biopsy and stage migration of breast cancer

3. Sentinel lymph node micrometastasis in human breast cancer: An update

4. Use of 21-gene recurrence score assay to individualize adjuvant chemotherapy recommendations in ER+/HER2− node positive breast cancer—A National Cancer Database study

5. Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedure

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of post-mastectomy adjuvant chemotherapy for the treatment of patients with prognostic stage IB breast cancer: A SEER-based study;Asian Journal of Surgery;2023-09

2. Evaluation of adjuvant therapy for T1-2N1miM0 breast cancer without further axillary lymph node dissection;Frontiers in Surgery;2023-01-06

3. Oncotype DX Breast Recurrence Score®: A Review of its Use in Early-Stage Breast Cancer;Molecular Diagnosis & Therapy;2020-07-01

4. Comparison of 21-gene assay and St.Gallen International Expert Consensus in the treatment decision for patients with early invasive breast cancers;Cancer Biology & Therapy;2019-10-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3